Medical News

RSS

Noven completes LDMP Phase 3 studies on menopausal VMS

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.

21 Mar 2012

Drexel University to establish nation's first autism center

Drexel University has received a gift of $1.5 million from the Charles and Barbara Close Foundation, founded by Drexel alumnus Charles Close ('36), to help establish the A.J. Drexel Autism Institute.

21 Mar 2012

Babies fed on demand associated with higher IQ scores

A new study suggests that babies who are breast-fed or bottle-fed to a schedule do not perform academically as well at school as their demand-fed peers. The finding is based on the results of IQ tests and school-based SATs tests carried out between the ages of five and 14, which show that demand-feeding was associated with higher IQ scores.

21 Mar 2012

Curcumin can help prevent clumping of proteins in Parkinson's

Curcumin, a compound found in the spice turmeric, is proving effective at preventing clumping of a protein involved in Parkinson's disease, says a Michigan State University researcher.

21 Mar 2012

Enzo Life Sciences, Cosmo Bio expand business arrangement

Enzo Biochem Inc. announced today an expanded business arrangement between its wholly owned subsidiary, Enzo Life Sciences, and Tokyo-based Cosmo Bio Co., Ltd..

21 Mar 2012

IQMS releases new version of ERP software, EnterpriseIQ

IQMS, a manufacturing ERP software developer with an ongoing, proactive commitment to its product and relationships, today announced the release of a new version of its manufacturing ERP software, EnterpriseIQ. Featuring more than 1,000 enhancements and reports across all aspects of the system, IQMS' newest release again demonstrates its commitment to the product and its clients.

21 Mar 2012

New drug makes chemotherapy more effective in treating acute myeloid leukemia

Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.

21 Mar 2012

Study tests new method of sound simulation for treating tinnitus

A new clinical trial is to test whether a pocket-sized device that uses sound simulation to reboot faulty 'wiring' in the brain could cure people with the debilitating hearing disorder tinnitus.

21 Mar 2012

NCCN issues first ever clinical practice guidelines for ALL

The National Comprehensive Cancer Network has issued its first ever NCCN Clinical Practice Guidelines in Oncology for Acute Lymphoblastic Leukemia.

21 Mar 2012

ISCO fourth quarter revenue increases 110% to $1.1 million

International Stem Cell Corporation today announced year-end financial results for the year ended December 31, 2011.

21 Mar 2012

Meda's Astepro receives registration approval in Europe

Astepro has received registration approval in Europe via the decentralized procedure. Astepro is a new nasal spray for the treatment of allergic rhinitis.

21 Mar 2012

Viewpoints: Rep. Ryan on his budget plan; Obama's contraceptive mandate could hurt McCaskill in tight Missouri race

On the critical issues of health security and tax reform, our budget draws a clear distinction between serious reformers and those who stand in the way of the growing bipartisan consensus for principled solutions. Our budget's Medicare reforms make no changes for those in or near retirement. For those who will retire a decade from now, our plan provides guaranteed coverage options financed by a premium-support payment. And this year, our budget adds even more choices for seniors, including a traditional fee-for-service Medicare option.

21 Mar 2012

Healthper mobile application now available for Apple devices

Healthper, Inc., a social game-based health engagement and achievement platform, announced today the launch of a mobile application for Apple mobile devices.

21 Mar 2012

Cardium commences Generx Phase 3 registration study in myocardial ischemia

Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.

21 Mar 2012

FDA approves Watson's generic BONIVA ANDA to treat osteoporosis in women

Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc. has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Ibandronate 150mg tablets, the generic equivalent to Roche's BONIVA tablets.

21 Mar 2012

PSG closes acquisition of Artemetrx

Pharmaceutical Strategies Group, LLC, America's largest independent pharmacy benefits consulting firm, has closed on its acquisition of Artemetrx Health Resources, the company announced today.

21 Mar 2012

Lexicon receives FDA Orphan Drug designation for telotristat etiprate to treat carcinoid syndrome

Lexicon Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted its request for Orphan Drug designation for telotristat etiprate (LX1032) for the treatment of carcinoid syndrome.

21 Mar 2012

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease, today announced positive data from its Phase 1 trial of AKB-9778 for the treatment of diabetic macular edema.

21 Mar 2012

IGI fourth quarter total revenues increase 21% to $2.1M

IGI Laboratories, Inc., a New Jersey based topical generic drug development and manufacturing company, provided its financial results for the fourth quarter and year ended December 31, 2011.

21 Mar 2012